Skip to main content
. Author manuscript; available in PMC: 2014 Jul 15.
Published in final edited form as: Cancer Res. 2013 May 30;73(14):4395–4405. doi: 10.1158/0008-5472.CAN-12-3765

Fig.6.

Fig.6

OHT triggers K-Ras degradation in multiple tumor types. Whole cell lysates from (A) glioma, (B, C) MPNST, (D, E) pancreatic, (F, G) colon and (H, I) breast cancer cell lines demonstrated a decrease in K-Ras levels following OHT treatment (48 hours)